Klichinsky Michael
SEC insider (Form 3/4/5 filer). CIK 0001967221. Chief Scientific Officer at Carisma Therapeutics Inc. (CARM). 6 reported Form 4/5 transactions since Sep 2024; latest on Oct 7, 2025. Located in PHILADELPHIA, PA.
Companies Klichinsky Michael has filed insider reports for
- Carisma Therapeutics Inc. (CARM): Officer, Chief Scientific Officer
Klichinsky Michael
CIK: 0001967221
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Carisma Therapeutics Inc.
Discretionary Trading P&L
Holdings
Transaction History (6 total)
- Oct 7, 2025CARM
Carisma Therapeutics Inc.
ExerciseDirect57K shares at avg. $0.11$6K - Oct 7, 2025CARM
Carisma Therapeutics Inc.
SaleDirect57K shares at avg. $0.25$14K - Oct 3, 2025CARM
Carisma Therapeutics Inc.
SaleDirect119.3K shares at avg. $0.26$31K - Oct 2, 2025CARM
Carisma Therapeutics Inc.
SaleDirect200K shares at avg. $0.25$51K - Oct 1, 2025CARM
Carisma Therapeutics Inc.
SaleDirect165K shares at avg. $0.26$42K - Jan 28, 2025CARM
Carisma Therapeutics Inc.
AwardDirectStock Option (Right to Buy)
221K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Oct 7, 2025 | CARM Carisma Therapeutics Inc. | Exercise | 56,982 | $0.11 | $6,268 | Direct |
| Oct 7, 2025 | CARM Carisma Therapeutics Inc. | Sale | 56,982 | $0.25 | $14,485 | Direct |
| Oct 3, 2025 | CARM Carisma Therapeutics Inc. | Sale | 119,347 | $0.26 | $31,078 | Direct |
| Oct 2, 2025 | CARM Carisma Therapeutics Inc. | Sale | 200,000 | $0.25 | $50,860 | Direct |
| Oct 1, 2025 | CARM Carisma Therapeutics Inc. | Sale | 165,000 | $0.26 | $42,405 | Direct |
| Jan 28, 2025 | CARM Carisma Therapeutics Inc. | Award Stock Option (Right to Buy) | 221,000 | - | - | Direct |
1-6 of 6 transactions